Historically, the receptor for advanced glycation end products (RAGE) was thought to
exclusively play an important role under hyperglycemic conditions. However, more and …

Background—The beneficial effects of reperfusion therapies have been limited by the
amount of ischemic damage that occurs before reperfusion. To enable development of …

The family of RAGE ligands, including Advanced Glycation Endproducts (AGEs),
S100/calgranulins, High Mobility Group Box-1 (HMGB1) and amyloid β peptide (Aβ) and β …

Receptor for advanced glycation end products (RAGE) is a 45 kDa transmembrane receptor
of immunoglobulin family that can bind to various endogenous and exogenous ligands and …

The roles of thioredoxin-interacting protein (TXNIP) and receptor for advanced glycation end-
products (RAGE)-dependent mechanisms of NOD-like receptor family, pyrin domain …

Sepsis is one of the most common reasons for critically ill patients to be admitted to an
intensive care unit and, despite advances in overall medical care, it represents a major …

Sepsis is a common cause of acute respiratory distress syndrome (ARDS) associated with a
high mortality. A panel of biomarkers (BMs) to identify septic patients at risk for developing …

Receptor for advanced glycation end products (RAGE) is an immunoglobulin-like receptor
present on cell surface. RAGE binds to an array of structurally diverse ligands, acts as a …

Introduction: Sepsis is characterized by a dysregulated host response to infection. Sepsis-
associated morbidity/mortality demands concerted research efforts toward therapeutic …

Objectives: To determine whether baseline plasma levels of the receptor for advanced
glycation end products (RAGE), a novel marker of alveolar type I cell injury, are associated …